These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11310596)
21. Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases. Walker B; McCarthy N; Healy A; Ye T; McKervey MA Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):321-3. PubMed ID: 8343111 [TBL] [Abstract][Full Text] [Related]
22. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position. Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051 [TBL] [Abstract][Full Text] [Related]
23. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin. Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors. Marasini BP; Rahim F; Perveen S; Karim A; Mohammed Khan K; Atta-Ur-Rahman ; Choudhary MI Bioorg Chem; 2017 Feb; 70():210-221. PubMed ID: 28087168 [TBL] [Abstract][Full Text] [Related]
25. 13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor. Djurdjevic-Pahl A; Hewage C; Malthouse JP Biochem J; 2002 Mar; 362(Pt 2):339-47. PubMed ID: 11853541 [TBL] [Abstract][Full Text] [Related]
26. Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin. Harvey AJ; Abell AD Bioorg Med Chem Lett; 2001 Sep; 11(18):2441-4. PubMed ID: 11549442 [TBL] [Abstract][Full Text] [Related]
27. Benzoxazin-4-ones as novel, easily accessible inhibitors for rhomboid proteases. Yang J; Barniol-Xicota M; Nguyen MTN; Ticha A; Strisovsky K; Verhelst SHL Bioorg Med Chem Lett; 2018 May; 28(8):1423-1427. PubMed ID: 29506958 [TBL] [Abstract][Full Text] [Related]
28. A novel method for selection of chymotrypsin inhibitors from a phage peptide library. Liu Y; Li B; Zhang S; Li T; Zhou H; Li W; Smith R; de Jersey J Biochem Mol Biol Int; 1998 Jun; 45(1):155-61. PubMed ID: 9635139 [TBL] [Abstract][Full Text] [Related]
29. A comparative study of antichymotryptic and anticholinesterase activity of organophosphorus quasi-substrate inhibitors. Rozengart EV Dokl Biochem Biophys; 2008; 419():82-7. PubMed ID: 18505164 [No Abstract] [Full Text] [Related]
30. Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivo. Kinder DH; Elstad CA; Meadows GG; Ames MM Invasion Metastasis; 1992; 12(5-6):309-19. PubMed ID: 1298742 [TBL] [Abstract][Full Text] [Related]
31. Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin. Ghani U; Ng KK; Atta-ur-Rahman ; Choudhary MI; Ullah N; James MN J Mol Biol; 2001 Nov; 314(3):519-25. PubMed ID: 11846564 [TBL] [Abstract][Full Text] [Related]
32. alpha-Chymotrypsin inhibition studies on the lignans from Vitex negundo Linn. Arif Lodhi M; Iqbal Choudhary M; Malik A; Ahmad S J Enzyme Inhib Med Chem; 2008 Jun; 23(3):400-5. PubMed ID: 18569346 [TBL] [Abstract][Full Text] [Related]
33. 1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors. Crocetti L; Giovannoni MP; Schepetkin IA; Quinn MT; Khlebnikov AI; Cantini N; Guerrini G; Iacovone A; Teodori E; Vergelli C Bioorg Med Chem; 2018 Nov; 26(21):5583-5595. PubMed ID: 30385225 [TBL] [Abstract][Full Text] [Related]
34. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Oleksyszyn J; Powers JC Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones. Aoyama Y; Uenaka M; Konoike T; Hayasaki-Kajiwara Y; Naya N; Nakajima M Bioorg Med Chem Lett; 2001 Jul; 11(13):1691-4. PubMed ID: 11425539 [TBL] [Abstract][Full Text] [Related]
36. Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones. Kreutter K; Steinmetz AC; Liang TC; Prorok M; Abeles RH; Ringe D Biochemistry; 1994 Nov; 33(46):13792-800. PubMed ID: 7947790 [TBL] [Abstract][Full Text] [Related]
37. Kinetics of the interaction of chymotrypsin with eglin c. Faller B; Bieth JG Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):27-32. PubMed ID: 1741752 [TBL] [Abstract][Full Text] [Related]
38. Detection of native peptides as potent inhibitors of enzymes. Crystal structure of the complex formed between treated bovine alpha-chymotrypsin and an autocatalytically produced fragment, IIe-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-Trp-Pro-Trp, at 2.2 angstroms resolution. Singh N; Jabeen T; Sharma S; Roy I; Gupta MN; Bilgrami S; Somvanshi RK; Dey S; Perbandt M; Betzel C; Srinivasan A; Singh TP FEBS J; 2005 Jan; 272(2):562-72. PubMed ID: 15654893 [TBL] [Abstract][Full Text] [Related]
39. Amino acids and peptides. XXIX. Synthesis of peptide fragments related to active center of eglin c and studies on the relationship between their structure and their inhibitory activity against cathepsin G and alpha-chymotrypsin. Nakabayashi K; Tsuboi S; Fujimoto T; Okada Y; Nagamatsu Y; Yamamoto J Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3249-52. PubMed ID: 2092930 [TBL] [Abstract][Full Text] [Related]
40. Serine protease inhibition by a silanediol peptidomimetic. Singh S; Sieburth SM Org Lett; 2012 Sep; 14(17):4422-5. PubMed ID: 22894760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]